Collinsonia canadensis 200C (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Collinsonia canadensis 200C drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Collinsonia canadensis
SUBSTANCE NAME: COLLINSONIA CANADENSIS ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-13
END MARKETING DATE: 0000-00-00


Collinsonia canadensis 200C HUMAN OTC DRUG Details:

Item DescriptionCollinsonia canadensis 200C from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 200([hp_C]/1)
START MARKETING DATE: 2015-06-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-1115_18639ffe-84a6-2dcb-e054-00144ff8d46c
PRODUCT NDC: 69152-1115
APPLICATION NUMBER:

Other COLLINSONIA CANADENSIS ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.COLLINSONIA CANADENSIS
Paramesh Banerji Life Sciences LLCCollinsonia canadensis 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCOLLINSONIA CANADENSIS
Washington Homeopathic ProductsCollinsonia canadensis